Osaic Holdings’s Edesa Biotech EDSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1
Closed -$5 7349
2023
Q3
$5 Hold
1
﹤0.01% 7353
2023
Q2
$6 Hold
1
﹤0.01% 7420
2023
Q1
$4 Sell
1
-14
-93% -$146 ﹤0.01% 7474
2022
Q4
$0 Hold
15
﹤0.01% 7239
2022
Q3
$0 Hold
15
﹤0.01% 7310
2022
Q2
$0 Hold
15
﹤0.01% 7407
2022
Q1
$0 Hold
15
﹤0.01% 7303
2021
Q4
$1K Hold
15
﹤0.01% 7165
2021
Q3
$1K Hold
15
﹤0.01% 7003
2021
Q2
$1K Hold
15
﹤0.01% 6839
2021
Q1
$1K Hold
15
﹤0.01% 6637
2020
Q4
$0 Sell
15
-4
-21% -$163 ﹤0.01% 6436
2020
Q3
$1K Hold
19
﹤0.01% 5993
2020
Q2
$1K Sell
19
-1
-5% -$23 ﹤0.01% 5922
2020
Q1
$0 Buy
+20
New +$411 ﹤0.01% 6093

Other funds holding EDSA

Osaic Holdings's EDSA Position: Q4 2023 in Review

Osaic Holdings sold out of Edesa Biotech (EDSA) in Q4 2023, closing a stake of 1 share — an estimated $5 sold.

Osaic Holdings first reported a position in EDSA in Q1 2020 and held it in 15 quarters. The position peaked at $1K in Q4 2021. 19 funds tracked by Wall St. Rank hold EDSA as of Q4 2023.

  • Osaic Holdings reported no remaining Edesa Biotech position as of Q4 2023 after selling out during the quarter.
  • Osaic Holdings sold 1 Edesa Biotech share in Q4 2023, an estimated $5.
  • Osaic Holdings first reported a position in Edesa Biotech in Q1 2020 and held it in 15 quarters.
  • Osaic Holdings's Edesa Biotech position peaked at $1K in Q4 2021.
  • 19 funds tracked by Wall St. Rank held Edesa Biotech as of Q4 2023.

Based on Osaic Holdings's 13F filing for Q4 2023, filed 12 Feb 2024.